期刊文献+

Clinical features and diagnosis for Chinese cases with malignant hyperthermia: a case cluster from 2005 to 2007 被引量:8

Clinical features and diagnosis for Chinese cases with malignant hyperthermia: a case cluster from 2005 to 2007
原文传递
导出
摘要 Background Malignant hyperthermia (MH), manifesting as MH crisis during and/or after general anesthesia, is a potentially fatal disorder in response to volatile anesthetics and depolarizing muscle relaxants. Though typical features of MH episode can provide clues for clinical diagnosis, MH susceptibility is confirmed by in vitro caffeine-halothane contracture test (CHCT) in western countries. It is traditionally thought that MH has less incidence and fewer typical characteristics in Chinese population than their western counterparts because of the different genetic background. In this study, we investigated the clinical features of MH in Chinese cases and applied the clinical grading scale and CHCT for diagnosis of MH. Methods A cluster of three patients with MH, from January 2005 to December 2007, were included in the study. Common clinical presentations and the results of some lab examinations were reported in detail. The method of the clinical grading scale of diagnosis of MH was applied to estimate the qualitative likelihood of MH and predict MH susceptibility. Muscle fibers of femoral quadriceps of the patients were collected and CHCT was performed to confirm the diagnosis of MH. Results The clinical grading scales of diagnosis of the disease for these cases were all ranked grade D6, suggesting almost diagnosed ones. And the results of caffeine test were positive correspondingly, indicating that the patients should be diagnosed as MH susceptibility (MHS) according to diagnostic criteria of the North America MH group, which were already confirmed by clinical presentations and biochemical results. Conclusions These Chinese cases manifest as MH crisis. The clinical grading scale of diagnosis of MH may provide clues for clinical diagnosis. CHCT can also be used in confirming diagnosis of MH in Chinese cases though they have different genetic background from their western counterparts. Background Malignant hyperthermia (MH), manifesting as MH crisis during and/or after general anesthesia, is a potentially fatal disorder in response to volatile anesthetics and depolarizing muscle relaxants. Though typical features of MH episode can provide clues for clinical diagnosis, MH susceptibility is confirmed by in vitro caffeine-halothane contracture test (CHCT) in western countries. It is traditionally thought that MH has less incidence and fewer typical characteristics in Chinese population than their western counterparts because of the different genetic background. In this study, we investigated the clinical features of MH in Chinese cases and applied the clinical grading scale and CHCT for diagnosis of MH. Methods A cluster of three patients with MH, from January 2005 to December 2007, were included in the study. Common clinical presentations and the results of some lab examinations were reported in detail. The method of the clinical grading scale of diagnosis of MH was applied to estimate the qualitative likelihood of MH and predict MH susceptibility. Muscle fibers of femoral quadriceps of the patients were collected and CHCT was performed to confirm the diagnosis of MH. Results The clinical grading scales of diagnosis of the disease for these cases were all ranked grade D6, suggesting almost diagnosed ones. And the results of caffeine test were positive correspondingly, indicating that the patients should be diagnosed as MH susceptibility (MHS) according to diagnostic criteria of the North America MH group, which were already confirmed by clinical presentations and biochemical results. Conclusions These Chinese cases manifest as MH crisis. The clinical grading scale of diagnosis of MH may provide clues for clinical diagnosis. CHCT can also be used in confirming diagnosis of MH in Chinese cases though they have different genetic background from their western counterparts.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第10期1241-1245,共5页 中华医学杂志(英文版)
关键词 malignant hyperthermia intraoperative complications DIAGNOSIS malignant hyperthermia intraoperative complications diagnosis
  • 相关文献

参考文献1

二级参考文献12

  • 1王颖林,郭向阳,罗爱伦.恶性高热诊断和治疗的研究进展[J].中华麻醉学杂志,2006,26(1):92-94. 被引量:22
  • 2王颖林,郭向阳,罗爱伦.我国大陆恶性高热病例的分析[J].中华麻醉学杂志,2006,26(2):107-109. 被引量:45
  • 3Abraham RB, Adnet P, Glauber V, et al. Malignant hyper-thermia [J]. Postgrad Med J, 1998, 74(867) :11-17.
  • 4Hopkins PM. Malignant hyperthermia: advances in clinical management and diagnosis [ J ]. Br J Anaesth, 2000, 85 (1) :118-128.
  • 5Gunilla I, Eva RT. Comparison between the European and North American protocols for diagnosis of malignant hyper-thermia susceptibility in humans [ J ]. Anesth Analg, 1999, 88(5) :1155-1160.
  • 6Litman RS, Rosenberg H. Malignant hyperthermia: update on susceptibility testing [ J ]. JAMA, 2005, 293 (23) : 2918-2924.
  • 7Sambuughin N, Muldoon S, Barbara BW. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population [ J ]. Anaesthesiology, 2005, 102(3) :515-521.
  • 8Mauritz W, Hackl W, Winkler M. Malignant hyperthermia: state of the art [J]. Acta Anaesthesiol Scand, 1997, 111 (suppl) :310-312.
  • 9McCarthy EJ. Malignant h yperthermia: pathophysiology, clinical presentation, and treatment [J]. AACN Clin Issues, 2004, 15(2):231-237.
  • 10Girard T, Treves S, Voronkov E, et al. Molecular genetic testing for malignant hyperthermia susceptibility [ J ]. Anesthesiology, 2004, 100(5) :1076-1080.

共引文献6

同被引文献18

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部